NL-OMON38380
Completed
N/A
DiPAR: Diagnosing Parkinson*s Disease by neuromuscular function evaluation - DiPAR
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- movement disorders
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All subjects
- •\- right\*handed
- •\- informed consent
- •\- ability to hold a pen for at least half an hour
- •PD patients
- •\- diagnosis according to the UK Parkinson\*s Disease Society Brain Bank clinical diagnostic criteria
- •\- symptoms scored as Hoehn \& Yahr I\*III
- •\- age: \>50 years
- •Essential tremor
- •\- diagnosis according to the criteria defined by the Tremor Investigation Group for more than 5 years
Exclusion Criteria
- •All subjects
- •\- (other) neurological or motor disorder (than that included for)
- •\- Mini Mental State Examination (MMSE) score \<26
- •\- Use of medication influencing movement other than for Parkinson's disease or essential tremor
- •PD patients
- •\- Not willing to comply with overnight\-withdrawal of Parkinson\-related medication
- •\- Tremor\-dominant PD
- •ET patients
- •\- Not willing to comply with medication withdrawal, starting 7 days prior to study investigation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Quantification of Parkinson*s Disease motor symptoms using the PowerGloveParkinson's diseasePD10028037NL-OMON40878Academisch Medisch Centrum35
Recruiting
N/A
Profiling Parkinson’s diseaseParkinson's diseaseNL-OMON21445Amsterdam UMC, location VUmc1,515
Recruiting
N/A
Differential diagnostics in Parkinsons Disease and the Atypical Parkinsonian DisordersParkinson's Disease10028037NL-OMON32744niversitair Medisch Centrum Sint Radboud150
Recruiting
N/A
Profiling Parkinson's diseaseNL-OMON54513Vrije Universiteit Medisch Centrum1,515
Active, Not Recruiting
Phase 1
Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect.(Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) - N/AEUCTR2004-004139-74-DKeurologisk afdeling F12